BioSpace News Archive

Business

Agenus Reports Third Quarter 2023 Results

Agenus Inc., a leader in discovering and developing novel immunological agents to treat various cancers, announced results for the third quarter 2023.

November 7, 2023
·
10 min read
Business

NRx Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 14, 2023

NRx Pharmaceuticals, Inc. announced that it will release its third quarter 2023 financial results after the market closes on Tuesday, November 14, 2023, via press release, which will be available on the Company’s website at https://ir.nrxpharma.com/press-releases.

November 7, 2023
·
2 min read
Business

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

Mersana Therapeutics, Inc. provided a business update and reported financial results for the third quarter ended September 30, 2023.

November 7, 2023
·
9 min read
Business

uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, reported its financial results for the third quarter of 2023 and highlighted recent progress across its business.

November 7, 2023
·
12 min read
Biotech Beach

CLS Americas and HALO Diagnostics Initiate Prostate Cancer Clinical Study using TRANBERG Focal Laser Ablation SystemMinimally Invasive, Outpatient Treatment Provides High Precision Laser Focal Therapy of Prostate Tumors in an ASC

Clinical Laserthermia Systems Americas, Inc. and HALO Diagnostics announced a 25-patient clinical study using the TRANBERG™ Thermal Therapy System to perform image-guided focal laser ablation of low-to-intermediate risk prostate cancer in patients.

November 7, 2023
·
4 min read
Business

Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

November 7, 2023
·
16 min read
Business

Axogen, Inc. Reports 2023 Third Quarter Financial Results

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the third quarter ended September 30, 2023.

November 7, 2023
·
18 min read
Drug Development

Milestone Pharmaceuticals to Host Investor and Analyst Webcast to Review Data from ReVeRA Phase 2 Study of Etripamil in AFib-RVR

Milestone Pharmaceuticals Inc. announced that the Company will host a virtual investor and analyst webcast on Monday, November 13, 2023 at 8:00 a.m. ET.

November 7, 2023
·
6 min read
Business

Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates

Fusion Pharmaceuticals Inc. announced financial results for the third quarter ended September 30, 2023 and provided an update on clinical and corporate developments.

November 7, 2023
·
12 min read
Genetown

Remix Therapeutics Announces Participation in Jefferies 2023 London Healthcare Conference

Remix Therapeutics, a biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, announced that the Company will be participating in the Jefferies London Healthcare Conference taking place November 14-16, 2023.

November 7, 2023
·
1 min read